Patient-Centric Approaches for Phase I Combination Trials Come on Stage
Date
2023-08-04Permanent link
https://hdl.handle.net/11351/10254DOI
10.1158/2159-8290.CD-23-0534
ISSN
2159-8290
PMID
37269291
Abstract
A disruptive clinical trial design allowed Drilon and colleagues to demonstrate proof of concept of the potential of PF-07284892 to overcome resistance mechanisms to targeted therapies in the clinic.
Keywords
Combination trials; CancerBibliographic citation
Hernando-Calvo A, Garralda E. Patient Centric Approaches for Phase I Combination Trials Come on Stage. Cancer Discov. 2023 Aug 4;13(8):1762–64.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
- VHIO - Articles científics [1250]
The following license files are associated with this item:





